UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial

BMC cancer, 2019-10, Vol.19 (1), p.979-979, Article 979

2019

Volltextzugriff (PDF)

R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

Strahlentherapie und Onkologie, 2021-01, Vol.197 (1), p.8-18

2021

Volltextzugriff (PDF)

Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12

Annals of oncology, 2019-07, Vol.30, p.iv129-iv129

2019

Volltextzugriff (PDF)

622P Evaluation of the metastatic colorectal cancer score (mCCS) in predicting outcome for patients with RAS wild type metastatic colorectal cancer (mCRC) treated with first-line (1L) panitumumab (PAN) plus FOLFIRI/FOLFOX: Updated interim results of the non-interventional study VALIDATE

Annals of oncology, 2023-10, Vol.34, p.S445-S445

2023

Volltextzugriff (PDF)

53MO Nal-IRI and 5-FU/LV compared to 5-FU/LV in patients with cholangio- and gallbladder carcinoma previously treated with gemcitabine-based therapies (NALIRICC – AIO-HEP-0116)

Annals of oncology, 2022-09, Vol.33, p.S563-S564

2022

Volltextzugriff (PDF)

1624P Predictive factors for treatment success of second-line Nal-IRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216)

Annals of oncology, 2023-10, Vol.34, p.S899-S900

2023

Volltextzugriff (PDF)

LBA10 Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group

Annals of oncology, 2021-09, Vol.32, p.S1282-S1282

2021

Volltextzugriff (PDF)

P-7 Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria – BERING CRC

Annals of oncology, 2022-06, Vol.33, p.S248

2022

Volltextzugriff (PDF)

457P 1st-line panitumumab plus FOLFIRI or FOLFOX for patients with RAS wildtype metastatic colorectal cancer in Germany: Interim results of the non-interventional study VALIDATE

Annals of oncology, 2020-09, Vol.31, p.S436-S436

2020

Volltextzugriff (PDF)

LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)

Annals of oncology, 2021-09, Vol.32, p.S1331-S1331

2021

Volltextzugriff (PDF)

O-011Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial

Radiotherapy and oncology, 2019-04, Vol.133, p.S257-S258

2019

Volltextzugriff (PDF)

Efficacy and Safety of Sequential Usage of Everolimus in Patients with Metastatic Renal Cell Carcinoma (MRCC) Previously Treated with Bevacizumab +/- Interferon (INF) Therapy. Results from the European Avator Retrospective Study

Annals of oncology, 2012-09, Vol.23, p.ix289

2012

Volltextzugriff (PDF)

How should patients with completely resected gastrointestinal stromal tumours (GIST) be followed up?

Zentralblatt für Chirurgie, 2005-12, Vol.130 (6), p.554

2005

Volltextzugriff (PDF)

Glomustumor des Magens: Ein Fallbericht

Chirurg, 2003-01, Vol.74 (1), p.65-68

2003

Volltextzugriff (PDF)

Glomus tumour of the stomach. A case report

Chirurg, 2003-01, Vol.74 (1), p.65-68

2003

Volltextzugriff (PDF)

Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial

Annals of hematology, 2023-12, Vol.102 (12), p.3383-3399

2023

Volltextzugriff (PDF)

Flow characteristics of water through a microchannel between two parallel plates with electrokinetic effects

The International journal of heat and fluid flow, 1997-10, Vol.18 (5), p.489-496

1997

Volltextzugriff (PDF)

Interfacial tension in polymer blends

Die Makromolekulare Chemie. Macromolecular symposia, 1998, Vol.126 (1), p.307-321

1998

Volltextzugriff (PDF)

Die charakterisierung der porosität von polyacrylnitril-faserstoffen im gelzustand

Acta polymerica, 1992-06, Vol.43 (3), p.151-158

1992

Volltextzugriff (PDF)

Cell proliferation of the intestinal mucosa in patients with familial adenomatosis coli. Autoradiography study

Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR, 1989, Vol.49 (1), p.29

1989

Volltextzugriff (PDF)

Die charakterisierung der porosität von polyacrylnitril‐faserstoffen im gelzustand

Acta polymerica, 1992-06, Vol.43 (3), p.151-158

1992

Volltextzugriff (PDF)

Autoradiography of DNA synthesis in colonic mucosa of patients with familial adenomatosis coli

Acta histochemica. Supplementband, 1990, Vol.39, p.249

1990

Volltextzugriff (PDF)

Palliative treatment of bronchial cancer with cytostatic agents

Les Bronches, 1971-03, Vol.21 (2), p.207

1971

Volltextzugriff (PDF)

Posters

Carcinogenic and Anticarcinogenic Factors in Food, 2000, p.429-518

2000

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Humans
(7)
Life Sciences & Biomedicine
(5)
Surgery
(4)
Adult
(3)
Female
(3)
Oncology
(3)
Physical Sciences
(3)
Adenomatous Polyposis Coli - Pathology
(2)
Aged
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Applied Sciences
(2)
Carcinoma, Pancreatic Ductal - Surgery
(2)
Colon - Pathology
(2)
Dna Replication
(2)
Endosonography
(2)
Exact Sciences And Technology
(2)
Fluorouracil - Administration & Dosage
(2)
Intestinal Mucosa - Pathology
(2)
Male
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial

R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12

622P Evaluation of the metastatic colorectal cancer score (mCCS) in predicting outcome for patients with RAS wild type metastatic colorectal cancer (mCRC) treated with first-line (1L) panitumumab (PAN) plus FOLFIRI/FOLFOX: Updated interim results of the non-interventional study VALIDATE

53MO Nal-IRI and 5-FU/LV compared to 5-FU/LV in patients with cholangio- and gallbladder carcinoma previously treated with gemcitabine-based therapies (NALIRICC – AIO-HEP-0116)

1624P Predictive factors for treatment success of second-line Nal-IRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216)

LBA10 Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group

P-7 Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria – BERING CRC

457P 1st-line panitumumab plus FOLFIRI or FOLFOX for patients with RAS wildtype metastatic colorectal cancer in Germany: Interim results of the non-interventional study VALIDATE

LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)

O-011Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12

OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial

Efficacy and Safety of Sequential Usage of Everolimus in Patients with Metastatic Renal Cell Carcinoma (MRCC) Previously Treated with Bevacizumab +/- Interferon (INF) Therapy. Results from the European Avator Retrospective Study

How should patients with completely resected gastrointestinal stromal tumours (GIST) be followed up?

Glomustumor des Magens: Ein Fallbericht

Glomus tumour of the stomach. A case report

Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial

Flow characteristics of water through a microchannel between two parallel plates with electrokinetic effects

Interfacial tension in polymer blends

Die charakterisierung der porosität von polyacrylnitril-faserstoffen im gelzustand

Cell proliferation of the intestinal mucosa in patients with familial adenomatosis coli. Autoradiography study

Die charakterisierung der porosität von polyacrylnitril‐faserstoffen im gelzustand

Autoradiography of DNA synthesis in colonic mucosa of patients with familial adenomatosis coli

Palliative treatment of bronchial cancer with cytostatic agents

Posters

Suchergebnisse filtern